The high-ranked pharmaceutical companies now have jumped into co-development of new improved drugs… while risk decreases, competition intensifies
Business trends in the pharmaceutical industry have been changed into a consortium form of participation with multiple pharmaceutical companies to develop a newimproved drug.
Especially, the high-ranked pharmaceutical companies, which had given lukewarm responses towards joint development, have ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
